Concentrix reported a $988 million loss, while operations provided $268 million in cash.
Concentrix (CNXC) reported a Q3 2026 net loss of $988.1M, including a $1.05B non-cash goodwill impairment charge. Revenue fell 1.2% YoY to $2.45B. Non-GAAP EPS rose 5% to $2.92. Operating cash flow was $268.2M. The dividend increased to $0.37 per share. Full-year revenue guidance is $9.83B-$9.88B, with an expected operating loss of $512M-$522M.
How this was made
The 30-second read
Why it matters
The earnings miss and impairment are likely to drive short-term selling pressure.
Market read
First‑report earnings release with material loss; traders may adjust positions today.
What to watch
Non‑GAAP earnings beat and modest free cash flow generation may soften the impact.
Background
Concentrix reported Q3 2026 results with a sizable net loss and a $1.05B goodwill impairment.
Ticker impact
Q3 2026 net loss of $988.1M and 1.2% revenue decline disclosed, with guidance for FY loss and lower revenue.
likely downside as market prices in the loss and impairment.
The surprise loss and $1.05B goodwill charge are material and new, prompting sell pressure.
Market effects
Technology services sector may see broader scrutiny of profit margins.
U.S. market participants may adjust exposure to outsourcing firms.
Limited to investors tracking US-listed BPO companies.
Counterpoint
The dividend increase could signal confidence in cash flow despite the loss.
Key entities
- companyConcentrix Corporation
US‑listed technology and services provider (NASDAQ: CNXC).
